TGF-β increases the self-renewal capacity of glioma-initiating cells, via Smad-dependent induction of leukemia inhibitory factor and the subsequent activation of JAK-STAT3 signaling [40]. The gene discussed is TGFB1; the disease is central nervous system cancer.